Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1 24Phase 3 12Phase 1/2 4Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 38Prostatic Neoplasms 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lung Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Neoplasms 14Leukemia 13Rectal Neoplasms 12Uterine Cervical Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 10Colorectal Neoplasms 10Colonic Neoplasms 10Sarcoma 9Leukemia, Myeloid, Acute 8Central Nervous System Neoplasms 8Brain Neoplasms 8Pain 7Ovarian Neoplasms 7Neuroblastoma 7Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Head and Neck Neoplasms 7Small Cell Lung Carcinoma 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Testicular Neoplasms 5Sezary Syndrome 5

Interventions

Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NIH × Leukemia, Myelomonocytic, Acute × Clear all
NCT00540956 2011-05-16

Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase NA Completed
40 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡